화이자, FDA에 백신 긴급사용 승인 신청<br /><br />Pfizer applied for emergency use authorization of its COVID-19 vaccine on Friday, raising hopes for an end to the global pandemic.<br />The submission to the U.S. FDA comes just days after the firm reported that final trial results showed the vaccine to be 95 percent effective in preventing the virus.<br />If approved for widespread use, distributions will be made before the year is up.<br />Earlier, Vice President Mike Pence said that vaccines would be rolled out across the country within 24 hours once they are confirmed to be safe and effective.<br />
